FORA Capital’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
FORA Capital's BOLD Position: Q1 2020 in Review
FORA Capital sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 17,291 shares — an estimated $1.03M sold.
FORA Capital first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $1.03M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.
- FORA Capital reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
- FORA Capital sold 17,291 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.03M.
- FORA Capital first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
- FORA Capital's Audentes Therapeutics, Inc position peaked at $1.03M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.
Based on FORA Capital's 13F filing for Q1 2020, filed 15 May 2020.